18 Hook Avenue
Unit 101
Toronto, ON M6P 1T4
Canada
416-848-4156
https://www.ventripoint.com
Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter:
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Dr. George Adams B.A.Sc., ICD.D., M.A.Sc., Ph.D. | Executive Chairman & Corporate Secretary | 194,63k | N/A | 1948 |
Mr. Hugh MacNaught | Interim CEO, President & Director | 8,17k | N/A | N/A |
Mr. Jimmy Jeon | Chief Financial Officer | N/A | N/A | N/A |
Mr. Hirotaka Katagiri | CTO & Business Development Division Director | N/A | N/A | N/A |
Mr. Jim Graba | Application Specialist & Chief Trainer | N/A | N/A | N/A |
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model that generates accurate heart volumetric measurements. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity of chemotherapy treatments for cancer, and Covid-19 related heart issues. The company was incorporated in 2005 and is headquartered in Toronto, Canada.
VentriPoint Diagnostics Ltd.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.